Can [F-18]afatinib PET/CT be used in identifying NSCLC patients with different EGFR mutational status: tracer quantification and assessment of tumor uptake

Eveline van de Stadt, Maqsood Yaqub, Alex Poot, Robert Schuit, Idris Bahce, E. Smit, Harry Hendrikse

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
JournalJournal of Nuclear Medicine
Volume60
Publication statusPublished - 1 May 2019

Cite this